Matching geography
Reports matching your search in:
 
 
US: 800.298.5699
Int'l: +1.240.747.3093
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
Region: All Regions > South America
Category: All Categories > Life Sciences > Pharmaceuticals > Drug Discovery
(11 reports matching your criteria)
 
Latin American Bioinformatics Market by Sector (Agriculture, Molecular Medicine, Research & Animal), Segment (Sequencing Platforms, Knowledge Management Tools & Data Analysis Services) & Application (Genomics, Proteomics & Drug Design) - Forecasts to 2017
3/7/2014 | published by: MarketsandMarkets
... is an integration of informatics and life sciences. It uses information technology, statistics, and algorithms for storing, retrieving, and analyzing biological data that is generated during life sciences research. In Latin America, bioinformatics is now ...  |  read more...
$4,650.00
Brazil Orthobiologics Market Outlook to 2020
3/7/2014 | published by: GlobalData
... and volume (in units) and average price data (in US dollars), within market categories – Bone Graft Substitutes, Viscosupplementation, Bone Allografts and Bone Growth Stimulators. The report also provides company shares and distribution shares data ...  |  read more...
$2,500.00
PharmaPoint: Hemophilia A and B - Argentina Drug Forecast and Market Analysis to 2022
11/30/2013 | published by: GlobalData
... use of recombinant FVIII and FIX replacement factors, and patients with severe forms of the disease receive frequent prophylactic infusions beginning from the first one or two years of life and often continuing through adulthood. ...  |  read more...
$4,995.00
A Product and Pipeline Analysis of the Latin American HIV, Chagas, Dengue, and Influenza H1N1 Therapeutics Markets
10/15/2013 | published by: Frost & Sullivan
... the human immunodeficiency virus (HIV), Chagas, dengue, and influenza H1N1 therapeutics markets in Latin America. General market trends are covered, and a competitive landscape, which highlights current drugs on the market as well as drugs ...  |  read more...
$4,000.00
BRIC: pharmahandbook
6/1/2013 | published by: VOI Consulting
... on the structural, regulatory and commercial aspects of the biopharmaceutical markets in each country, pharmahandbook’s 2013 BRIC report provides you with what you need to know in order to capi-talize on these vitally important but ...  |  read more...
$905.00
PharmaPoint: Hepatitis C Virus - Brazil Drug Forecast and Market Analysis to 2022
5/31/2013 | published by: GlobalData
... Hepatitis C is a liver infection caused by the hepatitis C virus (HCV) that results in acute or chronic presentation. The disease is often asymptomatic, but infected patients may experience fatigue, joint pain, itchy skin ...  |  read more...
$4,995.00
PharmaPoint: HIV - Brazil Drug Forecast and Market Analysis to 2022
1/31/2013 | published by: GlobalData
... causative agent of AIDS, has claimed millions of lives since its emergence. However, the advent of antiretroviral therapy (ART) has transformed the face of HIV/AIDS from a deadly disease to a manageable chronic condition for ...  |  read more...
$4,995.00
Emerging Market for Clinical Trials in Argentina - Major Cost Advantages over the US in Conducting Clinical Trials Will Encourage Drug Development
7/1/2011 | published by: GBI Research
... in Argentina - Major Cost Advantages over the US in Conducting Clinical Trials Will Encourage Drug Development” that provides key data, information and analysis of the major trends and issues affecting the clinical trial market ...  |  read more...
$3,500.00
Prostate Cancer - BRIC Drug Forecasts and Treatment Analysis to 2020
12/1/2010 | published by: GlobalData
... of information and analysis on the prostate cancer therapeutics market in the emerging BRIC countries. The report provides comprehensive information on prostate cancer, highlighting the treatment guidelines. It identifies and analyzes the key trends shaping ...  |  read more...
$3,000.00
Stakeholder Opinions: HIV in Emerging Markets (Brazil, Russia, India) - Growing need for second- and third-line therapies boosts commercial opportunity
5/25/2010 | published by: Datamonitor
... coverage coupled with a growing affluent middle class and private sector have turned countries like Brazil, Russia or India into a promising commercial opportunity. Scope Analysis of current HIV market dynamics across Brazil, Russia and ...  |  read more...
$3,800.00
Offshoring Clinical Trials (The Market for Clinical Trials in India, China, Mexico, Brazil, Russia and Israel.)
11/1/2007 | published by: Kalorama Information
... problems. This provides an opportunity for BRIC countries and other developing regions to grab a piece of the clinical trial market. Countries such as India and China have a vast population who are interested in ...  |  read more...
$1,500.00